Home » Stocks » Progyny

Progyny, Inc. (PGNY)

Stock Price: $25.87 USD -0.07 (-0.27%)
Updated Jul 8, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 2.20B
Revenue (ttm) 263.51M
Net Income (ttm) n/a
Shares Out 85.17M
EPS (ttm) -0.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 8, 2020
Last Price $25.87
Previous Close $25.94
Change ($) -0.07
Change (%) -0.27%
Day's Open 25.74
Day's Range 25.16 - 26.29
Day's Volume 835,127
52-Week Range 13.29 - 36.50

More Stats

Market Cap 2.20B
Enterprise Value 2.11B
Earnings Date (est) Dec 2, 2020
Ex-Dividend Date n/a
Shares Outstanding 85.17M
Float 35.16M
EPS (basic) n/a
EPS (diluted) -0.99
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.86M
Short Ratio 2.91
Short % of Float 24.56%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 8.36
PB Ratio 18.72
Revenue 263.51M
Operating Income n/a
Net Income n/a
Free Cash Flow n/a
Net Cash 91.63M
Net Cash / Share 1.08
Gross Margin 17.27%
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA 5.48%
ROE -10.40%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 5
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$29.67*
(14.69% upside)
Low
26.0
Current: 25.87
High
35.0
Target: 29.67
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017
Revenue23010548.58
Revenue Growth117.92%116.94%-
Gross Profit45.5119.437.40
Operating Income9.68-3.45-11.01
Net Income-8.570.66-12.45
Shares Outstanding20.745.545.68
Earnings Per Share-0.410.04-2.37
Operating Cash Flow-1.532.27-9.47
Capital Expenditures-2.96-0.58-0.61
Free Cash Flow-4.491.69-10.09
Cash & Equivalents80.380.134.69
Total Debt-0.255.19
Net Cash / Debt80.38-0.13-0.50
Assets15041.3234.96
Liabilities36.1630.2024.27
Book Value114-95.12-97.62
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Progyny, Inc.
Country United States
Employees 167
CEO David J. Schlanger

Stock Information

Ticker Symbol PGNY
Stock Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Unique Identifier NASDAQ: PGNY

Description

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption expenses for clients and their employees. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.